This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US District Court: Southern District of Florida - Accord Healthcare et al v. Acorda Therapeutics et al [complaint]

( April 1, 2013, 16:00 GMT | Official Statement) -- MLex Summary: Accord Healthcare and Intas Pharmaceuticals have filed a complaint against Acorda Therapeutics over its refusal to allow them to buy samples of its multiple-sclerosis drug Ampyra. Accord alleges that Acorda prevents distributors from selling Ampyra to generic manufacturers and improperly used the Food and Drug Administration's Risk Evaluation and Mitigations Strategies as a basis for refusing to sell the samples.See complaint below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections